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Nuclear factor-kappa B (NF-jB) comprises a family of in-
ducible transcription factors that serve as important reg-
ulators of the host immune and inflammatory responses.
The NF-jB signals are activated via the canonical and/or
noncanonical pathways in response to diverse stimuli.
The excessive action of NF-jB signal-transduction path-
ways frequently causes self-injurious phenomena such
as allergic diseases, vascular disorders, and ischemia–
reperfusion neuronal damage. In the inner ear, the role of
NF-jB has not been clarified because the activated NF-
jB signals potentially induce both cytoprotective and cy-
totoxic target genes after ototoxic stimulation. In the
present study, we investigated the response of NF-jB in
both the canonical and noncanonical pathways to acous-
tic overstimulation (117 dB/SPL/2 hr) and followed the
change of inflammatory factors (inducible nitric oxide
synthase [iNOS], intracellular adhesion molecule-1
[ICAM-1], and vascular cell adhesion molecule-1 [VCAM-
1]) in the cochlear lateral wall (CLW) and the rest of
cochlea (RoC). By means of immunohistochemistry com-
bined with confocal microscopy and reverse transcrip-
tase–polymerase chain reaction techniques, we found
the response of NF-jB family members (NF-jB1, 2,
RelA, and RelB) at the transcription level. After the NF-
jB signaling, the inflammatory factors were significantly
increased in the CLW and the RoC. Additionally, at the
protein level, the prominent expression of adhesion mole-
cules (ICAM-1 and VCAM-1) was observed in the tissue
around the capillaries in the stria vascularis. These
results show that acoustic overstimulation causes the
NF-jB signaling to overexpress the inflammatory factors
in the inner ear, and the up-regulation of the adhesion
molecules (ICAM-1 and VCAM-1) and iNOS potentially
influence the hemodynamics and the cellular integrity in
the stria vascularis. VC 2009 Wiley-Liss, Inc.
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The nuclear factor-kappa B (NF-jB)/Rel family is
a group of structurally and evolutionally conserved pro-
teins, which is expressed in all cell types and functions as
a sequence-specific transcription factor (Sen and Balti-
more, 1986; Ghosh et al., 1998). Five members of the
NF-jB/Rel family, NF-jB1 (p105/p50), NF-jB2
(p100/p52), RelA (p65), RelB, and c-Rel, are identified
in mammalian cells and known to exist as homo- or het-
erodimeric complexes in the cytoplasm (Ghosh et al.,
1998; Rothwarf and Karin, 1999). The NF-jB signals
are activated through either or both of two independent
signal-transduction (canonical and noncanonical) path-
ways in response to inflammation, infections, and other
stressful situations requiring rapid reprogramming of
gene expression (Ghosh et al., 1998; Rothwarf and
Karin, 1999; Senftleben et al., 2001). Although various
homo- and heterodimeric combinations possibly func-
tion in the NF-jB/Rel family, the heterodimers of NF-
jB1 and RelA in the canonical pathway as well as the
heterodimers of NF-jB2 and RelB in the noncanonical
pathway are considered to be predominant respectively
(Baeuerle and Henkel, 1994; Rothwarf and Karin, 1999;
Siebenlist et al., 2005). NF-jB signals trigger the expres-
sion of various target genes encoding inducible effectors
(e.g., inducible nitric oxide synthase [iNOS] and cyclo-
xgenase-2), adhesion molecules (e.g., intracellular adhe-
sion molecule-1 [ICAM-1] and vascular cell adhesion
molecule-1 [VCAM-1]), cytokines, and chemokines,
which play a critical role in innate and adaptive immune
responses (Baeuerle and Henkel, 1994; Ghosh et al.,
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1998; Ghosh and Karin, 2002). Furthermore, the NF-
jB/Rel family is involved in cell death, survival, prolif-
eration, development, and degeneration by inducing
antiapoptotic and proliferative factors (Beg et al., 1995;
Denk et al., 2000; Karin and Lin, 2002). On the other
hand, the overstimulation of NF-jB signals frequently
causes cellular and DNA damage from reactive oxygen
species (ROS) mediated by iNOS (Moncada et al.,
1991; Cuzzocrea et al., 2001; Conti et al., 2007) and
produces hemodynamic change associated with ICAM-1
and VCAM-1 (Collins et al., 1995; Sumagin and Sare-
lius, 2007). The overproductive and long-term activation
can lead to vascular insufficiency such as cardiovascular
disorders (Miwa et al., 1997; Ridker et al., 1998; Valen
et al., 2001), allergic tracheobronchial lesions in asthma
(Hart et al., 1998), and malignancy (Karin et al., 2002).
Several studies found that in the inner ear, the NF-
jB/Rel family is potentially required for normal hair cell
function including Ca21 homeostasis (Nagy et al., 2005;
Lang et al., 2006) and the signal-transduction pathways
can rapidly respond to ototoxic stimulants, such as noise
exposure and ototoxic drugs, to protect hair cells and spi-
ral ganglion cells (Jiang et al., 2005; Nagashima et al.,
2007). On the other hand, other studies suggested that
NF-jB induced overexpression of iNOS is presumably
involved in insults of the cochlear lateral wall (CLW) by
producing large amounts of ROS (Watanabe et al., 2002;
Shi and Nuttall, 2003; Masuda et al., 2006). Actually, the
cytoprotective role of the NF-jB/Rel family in the mu-
rine inner ear is incomplete or inefficient to acoustic
overstimulation (116 dB/SPL/2 hr) because a marked hair
cell degeneration occurs (Hirose and Liberman, 2003).
Thus, past studies revealed the noise-induced NF-jB acti-
vation and its potential roles for cytoprotection and cyto-
toxicity in the inner ear (Lang et al., 2006; Masuda et al.,
2006). There is, however, little information regarding the
deeper questions of which NF-jB signal-transduction
pathway is involved and what target genes may affect
cochlear function with acoustic overstimulation.
In the present study, we investigated the response
of the NF-jB/Rel family members (NF-jB1, NF-jB2,
RelA, and RelB) in canonical and noncanonical path-
ways at the transcription level by acoustic overstimula-
tion (117 dB/SPL/2 hr) and followed the time course of
inflammatory factors (iNOS, ICAM-1, and VCAM-1) in
the inner ear.
MATERIALS AND METHODS
Male CBA mice aged 10–12 weeks with normal hearing
were used. To determine the response of the NF-jB/Rel
family members (NF-jB1, NF-jB2, RelA, and RelB) in the
whole cochlea, six animals were randomly assigned to serve as
controls or as noise-exposed subjects and prepared for reverse
transcriptase–polymerase chain reaction (RT-PCR). For quan-
titative real-time PCR analysis, 18 animals were divided into
six groups: control group, 2-hr noise exposure (NE 2h)
group, 2-hr waiting after the NE 2h (NE 2h12h) group, 4-hr
waiting after the NE 2h (NE 2h14h) group, 6-hr waiting
after the NE 2h (NE 2h16h) group, and 12-hr waiting after
the NE 2h (NE 2h112h) group. Each group comprised three
animals. The noise exposure level was 117 dB/SPL/broadband
for 2 hr. After rats were humanely killed with an overdose of
ketamine hydrochloride (100 mg/kg, i.m.) and 2% xylazine
hydrochloride (10 mg/kg) (Abbott Laboratories, N. Chicago,
IL), the CLW tissues and the RoC tissues, which include the
organ of Corti with supporting cells and spiral ganglion cells,
were dissected and grouped from whole cochleas, and cDNA
samples were prepared for RT-PCR and quantitative real-
time PCR analysis. To evaluate the change of adhesion mole-
cules (ICAM-1 and VCAM-1) in the CLW, four animals
were divided into two groups, the control group and 14-hr
waiting after the NE 2h (NE 2h114h) group, and prepared for
immunohistochemistry. The procedures of this study were
reviewed and approved by the Institutional Animal Care and
Use Committee of the Oregon Health and Science University.
Immunohistochemistry
Cochleas were dissected from the control group and the
NE 2h114h group (n 5 2, in each) and fixed with 4% para-
formaldehyde in phosphate-buffered saline (PBS) for 4 hr, then
the CLW were isolated and permeabilized with 0.5% Triton
X-100 for 1 hr. After being immunoblocked with blocking so-
lution consisting of 10% goat serum/2% bovine serum albumin
(BSA) in PBS for 1 hr, the samples were incubated overnight
at 48C in the antibodies for ICAM-1 and VCAM-1 (rabbit
polyclonal anti-ICAM-1, rabbit polyclonal anti-VCAM-1,
diluted 1:100 with 5% BSA in PBS, Santa Cruz Biotechnol-
ogy). The specimens were also double labeled with propidium
iodide (PI; 500 nM, Molecular Probes/Invitrogen) for 30 min
at room temperature. The specimens were rinsed several times
with PBS and incubated with a secondary antibody (Alexa
Fluor 488 goat anti-rabbit, diluted 1:100 with 5% BSA in PBS,
Molecular Probes/Invitrogen) for 1 hr at room temperature.
After rinsing, the tissues were mounted and observed on a
Nikon Eclipse TE 300 inverted microscope fitted with a Bio-
Rad MRC 1024 confocal laser microscope system. Negative
control tissues were incubated with 5% BSA in PBS to replace
the primary antibodies and double labeled with PI.
Total RNA Extraction and cDNA Synthesis From
Cochlear Tissues
Total RNA was extracted from the cochleas isolated
from each group (n 5 3) divided into the CLW and the RoC
by with RNeasy Micro Kit (Qiagen, Valencia, CA) following
the standard protocol. First-strand cDNA of each sample was
synthesized from 1–2 lg of total RNA by with RETROscript
Kit (Ambion). The reaction was finally heat-inactivated. Sepa-
rately, the total RNA of whole cochleas was extracted from
six ears of the control and noise-exposed (NE 2h14h) sub-
jects (n 5 3 in each), and the cDNA was prepared for RT-
PCR by the same protocol.
RT-PCR and Quantitative Real-time PCR Analysis
Conserved regions spanning introns were selected to
design the primers for the NF-jB/Rel family: iNOS, adhe-
sion molecules and glyceraldehyde-3-phosphate dehydrogenase
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(GAPDH). The primers used were as follows: NF-jB1
(mouse Chr 3 NM_008689), forward, GAAATTCCTGATC
CAGACAAAAAC, reverse, ATCACTTCAATGGCCTCT
GTGTAG, 194-bp product; NF-jB2 (mouse Chr 19
NM_019408), forward, CTGGTGGACACATACAGGAA
GAC, reverse, ATAGGCACTGTCTTCTTTCACCTC, 195-
bp product; RelA (mouse Chr 19 NM_009045), forward,
CTTCCTCAGCCATGGTACCTCT, reverse, CAAGTCTT
CATCAGCATCAAACTG, 167-bp product; RelB (mouse
Chr 7 NM_009046), forward, CTTTGCCTATGATCCTTC
TGC, reverse, GAGTCCAGTGATAGGGGCTCT, 150-bp
product; iNOS (mouse Chr 11 NM_010927), forward, CTAT-
CAGGAAGAAATGCAGGAGAT, reverse, GAGCACGCT-
GAGTACCTCATT, 145-bp product; ICAM-1 (mouse Chr 9
NM_010493), forward, GTTTAAAAACCAGACCCTGGAA
CT, reverse, CGTCTGCAGGTCATCTTAGGAG, 153-bp
product; VCAM-1 (mouse Chr 3 NM_011693), forward,
CCGGCATATACGAGTGTGAAT, reverse, ATGGCAGG
TATTACCAAGGAAGAT, 151-bp product; GAPDH (mouse
Chr 6 NM_008084), forward, ATGTGTCCGTCGTGGATC
TGAC, reverse, AGACAACCTGGTCCTCAGTGTAG 132-
bp product. The cycling conditions of RT-PCR were 958C
for 2 min; up to 40 cycles of 958C for 30 sec, 608C for 30 sec,
728C for 30 sec; and a final 4-min extension at 728C. All prod-
ucts were amplified with Taq DNA polymerase (Promega,
Madison, WI) by DNA Engine Dyad (Bio-Rad, Hercules,
CA). The cDNA samples in each group were diluted 6-fold
with DNase-free water and were subjected independently three
times to real-time PCR with the same primers of RT-PCR
and SYBR Green PCR Master Mix (Applied Biosystems, CA)
by using the StepOnePlus Real-Time PCR System (Applied
Biosystems, CA). Cycling conditions of real-time PCR were
958C for 2 min; 40 cycles of 958C for 30 sec, 608C for 60 sec.
GAPDH was used as a reference gene, and relative quantifica-
tion analysis was determined via the 22DDCT method (Livak
and Schmittgen, 2001).
Statistical Analysis
Numerical results are presented as means 6 SD. The
significant differences between the data sets were assessed with
the Student’s t-tests. The differences were considered signifi-
cant at P < 0.05 and/or at P < 0.01.
RESULTS
Response of NF-jB/Rel Family to Acoustic
Overstimulation
The expression of the NF-jB/Rel family mem-
bers, NF-jB1, NF-jB2, RelA, and RelB, was observed
in the whole cochlea of the control group at 30 cycles
of the reaction in RT-PCR. GAPDH in the control
group was also confirmed at 24 cycles and used as an in-
ternal control to compare between the control group
and the NE 2h14h group. All members of the NF-jB/
Rel family in the NE 2h14h group were confirmed at
30 cycles and obviously enhanced relative to the control
group at the same number of cycles with no difference
in GAPDH at 24 cycles (Fig. 1A). We divided the coch-
leas into the CLW and the RoC to determine whether
Fig. 1. Response of the NF-jB/Rel family members to acoustic
overstimulation. A: PCR products of NF-jB1 (194 bp), NF-jB2
(195 bp), RelA (167 bp), and RelB (150 bp) in whole cochleas by
RT-PCR. Their intensity at 30 cycles in the NE 2h14h group is
higher than those of the control group. GAPDH (132 bp) was used
as a reference gene and compared at 24 cycles. B: Quantification of
the NF-jB/Rel family members’ expressions in the CLW and the
RoC by quantitative real-time PCR analysis. Error bars represent
SD. Each value estimated by the 22DDCT method represents a com-
parison with the control group defined as 1.0. Statistical differences
in the data sets between the control group and the NE groups were
assessed with Student’s t-tests and considered significant at *P < 0.05
and at **P < 0.01. Statistics: control/NE 2h; CLW: P 5 0.057,
RoC: P 5 0.271, control/NE 2h12h; CLW: P 5 0.054, RoC: *P
5 0.025, control/NE 2h14h; CLW: **P 5 0.003, RoC: **P 5
0.002.
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there is any expression difference between the CLW and
the RoC. Quantitative real-time PCR analysis indicated
that the expression of NF-jB members in the RoC was
slightly but statistically increased at 2 hr after NE 2h
(NE 2h12h) (control/NE 2h12h; CLW: P 5 0.054,
RoC: *P 5 0.025). The significant up-regulation in
both the CLW and the RoC was observed at 4 hr after
NE 2h (NE 2h14h) compared with the control group
(control/NE 2h14h; CLW: **P 5 0.003, RoC: **P 5
0.002) (Fig. 1B, Table I, Supp. Info. Table I). There-
fore, the result shows that the NF-jB/Rel family mem-
bers were induced in both the CLW and the RoC by
acoustic overstimulation (NE: 117 dB/SPL/2 hr), while
their initiated time in the CLW was slightly delayed
compared with that of the RoC.
Time Course of Inflammatory Factor
Up-regulation in CLW and RoC After
Acoustic Overstimulation
To investigate the inflammatory influence of NF-
jB signaling on the CLW and the RoC, inducible nitric
oxide synthase (iNOS), intracellular adhesion molecule-
1(ICAM-1), and vascular cell adhesion molecule-1
(VCAM-1) were selected as the inflammatory factors of
the NF-jB-induced target genes. Quantitative real-time
PCR analysis showed that in both the CLW and the
RoC, the up-regulation of ICAM-1 was first initiated at
NE 2h (control/NE 2h; CLW: *P 5 0.004, RoC: **P
5 0.002), and that of iNOS followed at NE 2h12h
(control/NE 2h12h; CLW: *P 5 0.008, RoC: **P 5
0.0005). In contrast, the induction of VCAM-1 expres-
sion was confirmed at NE 2h12h in the CLW, while
lacking significant increase in the RoC (control/NE
2h12h; CLW: *P 5 0.006, RoC: P 5 0.027) (Fig. 2A,
Table II, Supp. Info. Table II). In the RoC, the up-reg-
ulation of ICAM-1 and iNOS reached peak levels at
NE2 hr 1 2 hr and NE 2h14h respectively (ICAM-1:
21.26-fold at NE 2h12h, iNOS: 12.30-fold at NE
2h14h) and then rapidly declined at NE 2h16h (Fig.
2A, Table II, Supp. Info. Table II). In contrast, for the
target-gene expression patterns in the RoC, all inflam-
matory factors in the CLW progressively increased until











to RoC control 2-DDCT
CLW NF-jB1 28.30 21.32 6.98 6 0.11 0.00 6 0.11 1.00 (0.93–1.08)
Control NF-jB2 27.21 5.98 6 0.26 0.00 6 0.26 1.00 (0.84–1.20)
RelA 27.25 5.92 6 0.18 0.00 6 0.18 1.00 (0.88–1.13)
RelB 26.39 5.07 6 0.06 0.00 6 0.06 1.00 (0.96–1.04)
CLW NF-jB1 29.11 22.16 6.95 6 0.15 20.03 6 0.15 1.01 (0.92–1.13)
NE2h NF-jB1 27.85 5.69 6 0.20 20.20 6 0.20 1.14 (1.00–1.32)
RelA 27.63 5.46 6 0.21 20.46 6 0.21 1.38 (1.19–1.59)
RelB 27.06 4.90 6 0.31 20.17 6 0.31 1.13 (0.91–1.39)
CLW NF-jB1 27.84 21.44 6.40 6 0.17 20.58 6 0.17 1.49 (1.33–1.68)
NE2h12h NF-jB1 26.78 5.34 6 0.27 20.55 6 0.27 1.46 (1.21–1.77)
RelA 26.85 5.41 6 0.25 20.51 6 0.25 1.42 (1.20–1.69)
RelB 26.66 5.22 6 0.32 0.15 6 0.24 0.90 (0.76–1.06)
CLW NF-jB1 24.36 19.33 5.03 6 0.16 21.95 6 0.16 3.86 (3.46–4.32)
NE2h14h NF-jB1 23.60 4.27 6 0.15 21.62 6 0.15 3.07 (2.77–3.41)
RelA 23.92 4.08 6 0.25 21.34 6 0.25 2.53 (2.13–3.01)
RelB 22.50 3.17 6 0.32 21.90 6 0.32 3.73 (2.99–4.66)
RoC NF-jB1 29.74 22.27 7.54 6 0.21 0.00 6 0.21 1.00 (0.93–1.08)
Control NF-jB2 28.64 6.37 6 0.24 0.00 6 0.24 1.00 (0.84–1.20)
RelA 29.18 6.91 6 0.19 0.00 6 0.19 1.00 (0.88–1.13)
RelB 28.34 6.07 6 0.26 0.00 6 0.26 1.00 (0.96–1.04)
RoC NF-jB1 29.53 21.96 7.57 6 0.21 0.10 6 0.21 0.93 (0.93–1.24)
NE2h NF-jB2 28.09 6.13 6 0.37 20.24 6 0.33 1.18 (0.94–1.48)
RelA 28.62 6.66 6 0.32 20.25 6 0.32 1.19 (0.95–1.48)
RelB 28.17 6.20 6 0.42 0.13 6 0.42 0.91 (0.68–1.22)
RoC NF-jB1 29.15 21.90 7.25 6 0.20 20.22 6 0.20 1.16 (1.01–1.34)
NE2h12h NF-jB2 27.29 5.39 6 0.25 20.98 6 0.25 1.97 (1.66–2.35)
RelA 27.80 5.90 6 0.02 21.01 6 0.02 2.01 (1.99–2.31)
RelB 26.61 4.71 6 0.24 21.36 6 0.24 2.57 (2.17–3.03)
RoC NF-jB1 25.47 19.67 5.80 6 0.17 21.67 6 0.17 3.18 (2.83–3.58)
NE2h14h NF-jB2 24.79 5.12 6 0.19 21.25 6 0.25 2.38 (2.08–2.71)
RelA 24.98 5.31 6 0.20 21.60 6 0.20 3.03 (2.64–3.48)
RelB 23.90 4.23 6 0.28 21.84 6 0.28 3.58 (2.95–4.35)
yCT, threshold cycle, ‘‘Ave., average (6SD); CLW, cochlear lateral wall, Roc, rest of cochlea. NE, noise exposure.
*P < 0.05;
**P < 0.01.
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Fig. 2. Time course of inflammatory factors in the CLW after acoustic
overstimulation. A: Three graphs of the expression of iNOS, ICAM-
1, and VCAM-1 in the CLW and the RoC. The time course of
the target genes is indicated by the values estimated by the 22DDCT
method in quantitative RT-PCR analysis. Each value represents a
comparison with the control group defined as 1.0. Statistical differences
in the data sets between the control group and the NE groups were
assessed with Student’s t-tests and considered significant at P <
0.01(CLW: *, RoC: **). B: PCR products of iNOS (145 bp),
ICAM-1(153 bp), VCAM-1(151 bp), and GAPDH (132 bp) in the
CLW by RT-PCR. The intensities of iNOS, ICAM-1, and VCAM-1
were compared at 33 cycles between the CLW control group and the
CLW NE 2h16h group. GAPDH (132 bp) was also performed as a
reference gene and compared at 24 cycles. Error bars indicate the SD.
Statistics: (iNOS) control/NE 2h; CLW: P 5 0.383, RoC: P 5
0.024, control/NE 2h12h; CLW: P 5 0.008, RoC: P 5 0.001, con-
trol/NE 2h14h; CLW: P 5 0.001, RoC: P 5 0.002, control/NE
2h16h; CLW: P 5 0.001, RoC: P 5 0.486, control/NE 2h112h;
CLW: P 5 0.002, RoC: P 5 0.001, (ICAM-1) control/NE 2h;
CLW: P 5 0.004, RoC: P 5 0.002, control/NE 2h12h; CLW: P 5
0.0003, RoC: P 5 0.0002, control/NE 2h14h; CLW: P 5 0.0004,
RoC: P 5 0.001, control/NE 2h16h; CLW: P 5 0.0001<, RoC:
P 5 0.0004, control/NE 2h112h; CLW: P 5 0.002, RoC: P 5
0.232, (VCAM-1) control/NE 2h; CLW: P 5 0.092, RoC: P 5
0.335, control/NE 2h12h; CLW: P5 0.011, RoC: P5 0.027, control/
NE 2h14h; CLW: P 5 0.006, RoC: P 5 0.262, control/NE 2h16h;
CLW: P 5 0.0001, RoC: P 5 0.008, control/NE 2h112h; CLW: P 5
0.009, RoC: P5 0.004.
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NE 2h16h, and slowly decreased at NE 2h112h (Fig.
2A). In particular, the adhesion molecules were remark-
ably up-regulated in the CLW. The peak levels of
iNOS, ICAM-1, and VCAM-1 reached 12.64-fold,
112.99-fold, and 10.48-fold, respectively, at NE 2h16h
(Fig. 2A, Table II, Supp. Info. Table II). The RT-PCR
result also indicated the faint expression of iNOS,
ICAM-1, and VCAM-1 in the CLW control group at
33 cycles of the reaction and the substantial increases of
all factors in the CLW NE 2h16h group at the same
cycles (Fig. 2B). In contrast, there was no difference in
GAPDH at 24 cycles between the two groups (Fig. 2B).
Thus, these data indicated that acoustic overstimulation
(NE: 117 dB/SPL/2 hr) induced different NF-jB target
gene expression patterns in the values and the varieties
between the CLW and the RoC.
Expression of Adhesion Molecules in CLW by
Acoustic Overstimulation
To determine the changes in the adhesion mole-
cules (ICAM-1 and VCAM-1) at the protein level, the
CLW tissues in the NE 2h114h group were prepared
for immunohistochemistry and compared with that of
the control group. The analysis time point of NE
2h114h was selected as a sufficient interval to produce
the proteins following the peak of target gene expres-
sion. Figure 3 shows that the adhesion molecules were
slightly expressed in the stria vascularis (SV) under the
normal condition. The result was compatible with their
expression in the control group by RT-PCR (Fig. 2B).
Although ICAM-1 and VCAM-1 were widely expressed
in the CLW of the control group, their expression was








DDCT (Ave. DCT2 Ave. DCT
CLW (or RoC) control)
Normalized amount relative
to CLW (or RoC) control 22DDCT
CLW iNOS 33.31 21.19 12.12 6 0.21 0.00 6 0.21 1.00 (0.86–1.16)
Control ICAM-1 32.42 11.23 6 0.22 0.00 6 0.22 1.00 (0.86–1.16)
VCAM-1 27.22 6.03 6 0.31 0.00 6 0.31 1.00 (0.81–1.24)
CLW iNOS 34.63 22.56 12.07 6 0.29 20.05 6 0.29 1.04 (0.81–1.27)
NE2h ICAM-1 31.66 9.10 6 0.11 22.13 6 0.11 4.38 (4.06–4.72)*
VCAM-1 28.00 5.45 6 0.29 20.58 6 0.29 1.49 (1.22–1.83)
CLW iNOS 35.06 23.46 11.61 6 0.20 20.51 6 0.20 1.42 (4.50–5.24)*
NE2h12h ICAM-1 31.70 8.24 6 0.09 22.99 6 0.09 7.94 (7.46–8.46)*
VCAM-1 28.64 5.18 6 0.09 20.85 6 0.09 1.80 (1.69–1.92)*
CLW iNOS 34.30 24.28 9.84 6 0.11 22.28 6 0.11 4.86 (4.50–5.24)*
NE2h14h ICAM-1 31.25 6.72 6 0.04 24.51 6 0.04 22.78 (22.16–23.43)*
VCAM-1 28.64 3.66 6 0.13 22.37 6 0.13 5.17 (4.72–5.66)*
CLW iNOS 32.74 23.01 8.46 6 0.26 23.66 6 0.26 12.64 (10.56–15.14)*
NE2h16h ICAM-1 28.69 4.41 6 0.27 26.82 6 0.27 112.99 (93.70–136.24)*
VCAM-1 26.92 2.64 6 0.28 23.39 6 0.28 10.48 (8.63–12.73)*
CLW iNOS 29.96 20.43 9.53 6 0.43 22.59 6 0.43 6.02 (4.47–8.11)*
NE2h112h ICAM-1 27.18 6.75 6 0.23 24.48 6 0.23 22.32 (19.03–26.17)*
VCAM-1 24.55 4.12 6 0.31 21.91 6 0.31 3.76 (3.00–4.66)*
Roc iNOS 31.65 23.01 8.63 6 0.09 0.00 6 0.09 1.00 (0.94–1.06)
Control ICAM-1 33.87 10.86 6 0.32 0.00 6 0.32 1.00 (0.80–1.25)
VCAM-1 28.43 5.42 6 0.31 0.00 6 0.31 1.00 (0.81–1.24)
Roc iNOS 31.62 23.54 8.08 6 0.21 20.55 6 0.21 1.46 (1.27–1.69)
NE2h ICAM-1 33.06 9.52 6 0.21 21.34 6 0.21 2.53 (2.19–2.93)**
VCAM-1 29.05 5.50 6 0.26 0.06 6 0.26 0.96 (0.80–1.15)
Roc iNOS 31.16 25.75 5.42 6 0.12 23.21 6 0.12 9.25 (8.51–10.06)**
NE2h12h ICAM-1 32.19 6.45 6 0.12 24.41 6 0.12 21.26 (19.56–23.10)**
VCAM-1 30.65 4.90 6 0.20 20.52 6 0.20 1.43 (1.25–1.65)
Roc iNOS 30.57 25.67 5.01 6 0.32 23.62 6 0.32 12.30 (9.85–15.35)**
NE2h14h ICAM-1 32.49 6.82 6 0.29 24.04 6 0.29 16.45 (13.45–20.11)**
VCAM-1 30.90 5.23 6 0.38 20.19 6 0.38 1.14 (0.88–1.48)
Roc iNOS 30.96 22.28 8.63 6 0.11 0.00 6 0.11 1.00 (0.93–1.08)
NE2h16h ICAM-1 30.96 8.68 6 0.11 22.18 6 0.11 4.53 (4.20–4.89)**
VCAM-1 28.34 6.06 6 0.15 0.64 6 0.15 0.64 (0.37–0.71)
Roc iNOS 33.66 20.85 12.81 6 0.36 4.18 6 0.36 0.06 (0.04–0.07)
NE2h112h ICAM-1 31.84 10.99 6 0.32 20.13 6 0.32 0.91 (0.73–1.14)
VCAM-1 28.42 7.57 6 0.34 2.15 6 0.31 0.23 (0.18–0.28)
yCT, Threshold cycle; Ave, average (6SD); CLW, cochlear lateral wall; RoC, rest of cochlea; NE, Noise exposure.
*,**P < 0.01.
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remarkably up-regulated by acoustic overstimulation. In
particular, the labels of both ICAM-1 and VCAM-1
were most prominent at the marginal cell membranes
and the processes of intermediate cells associated with
capillaries in the SV (Fig. 3). The expression of VCAM-
1 is more intense than that of ICAM-1 in the SV and
their expressions coincided with each other. The nega-
tive controls (NC) in both the control group and the
NE 2h114h group showed no antibody labeling.
DISCUSSION
In the present study, we have shown that acoustic
overstimulation affects the transcription level of the NF-
jB/Rel family members (NF-jB1, NF-jB2, RelA, and
RelB) in the murine inner ear and the inflammatory fac-
tors (iNOS, ICAM-1, and VCAM-1) triggered by the
NF-jB signaling are up-regulated in the CLW and the
RoC. In the time-course study, the up-regulation of the
inflammatory factors presented as bimodal peaks between
the CLW and the RoC that originated from the slightly
delayed response of NF-jB to acoustic overstimulation
in the CLW. The early initiation of ICAM-1expression,
apparently preceding the transcriptional change of NF-
jB, implies its high sensitivity to the NF-jB signaling,
which derives from activating processes of NF-jB at the
protein level (i.e., phosphorylation and cleavage of NF-
jB/inhibitory protein complexes in the cytoplasm).
However, the later and robust response of ICAM-1 and
VCAM-1 at the transcription level correlated with their
large expression in the CLW at the protein level. Specif-
ically, ICAM-1 and VCAM-1 were overexpressed in the
SV, which is the most active ion transporting region in
the CLW and plays a key role in regulating ionic bal-
ance and producing endocochlear potential (EP) in the
endolymph (Wangemann, 2002; Nin et al., 2008).
The NF-jB/Rel family members, which are con-
stitutively produced through mRNA translations, are
degradated through proteolytic processes at the protein
level and generally exist as inactivated forms with inhibi-
tory proteins in the cytoplasm. In response to diverse
stimuli, the NF-jB signal-transduction pathways are
activated by phosphorylation and ubiquitin-dependent
cleavage of NF-jB/inhibitory protein complexes (Ghosh
et al., 1998; Siebenlist et al., 2005; Ghosh and Karin,
2002). In the light of evidence, the transcriptional
response of NF-jB to acoustic overstimulation might be
inadequate to implicate the whole process of the acti-
vated NF-jB signal-transduction pathways. However,
other evidence that NF-jB signals are constantly acti-
vated in prolonged and excessive stimulated cells (Hart
et al., 1998; Karin et al., 2002) supports our view that
the progressive production of NF-jB/Rel family at the
transcription level is potentially associated with its activa-
tion process. Therefore, in the present study, the up-reg-
ulation of the NF-jB/Rel family at the transcription
level implicates an activation of the NF-jB signal-trans-
duction pathways. Besides the elevations of NF-jB1 and
RelA, known as predominant forms in the canonical
Fig. 3. Expression of adhesion molecules in the SV. Panels are fluo-
rescent confocal images from whole mount preparations of the
CLW. The tissues were immunolabeled with ICAM-1 or VCAM-1
(green) and the nuclei were stained with PI (red). All images were
observed at the SV level. Merged images were compared between
the control group and the NE 2h114h group. Faint expression of
ICAM-1 and VCAM-1 was observed under normal condition in
comparison with negative controls. Scale bars 5 20 lm.
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pathway, the rise of NF-jB2 and RelB in the nonca-
nonical pathway also implies that both NF-jB signal-
transduction pathways are potentially activated in
response to acoustic overstimulation.
In the inner ear, acoustic overstimulation is well-
known to cause the apoptotic degeneration of cochlear
hair cells and spiral ganglion cells (Lang et al., 2006;
Nagashima et al., 2007) as well as the morphological and
physiological alteration in the CLW (Hirose and Liber-
man, 2003). In the SV, which is composed of three dif-
ferent cell types (marginal cells, intermediate cells, and
basal cells), and with well-developed capillaries, acoustic
overstimulation produces dramatic cellular damage such
as swollen marginal cells, shrunken intermediate cells,
and enlarged intrastrial spaces within 24 hr (Hirose and
Liberman, 2003). This damage leads to the severe physi-
ological changes of EP and ionic balance in the endo-
lymph for several days (Konishi et al., 1979; Hirose and
Liberman, 2003). It is noteworthy that the prominent
expression of ICAM-1 and VCAM-1 in the SV were
consistent with the region, which is preferentially vul-
nerable to acoustic stimulation (Hirose and Liberman,
2003). These findings support the view that there must
be a link between the inflammatory factors triggered by
NF-jB signaling and the histopathological changes in
the SV.
A number of past studies have already shown that
iNOS-induced ROS causes cellular and DNA damage
in the organs by compromising the structural and func-
tional integrity of the cell membrane and promoting
mutagenic deamination of DNA bases (Moncada et al.,
1991; Collins et al., 1995; Cuzzocrea et al., 2001; Shi
and Nuttall, 2003). Besides, adhesion molecules affect
hemodynamics by leukocyte-endothelial cell interactions
such as leukocyte rolling, adhesion, and transmigration
in the inflamed tissues, which ultimately lead to severe
energy depletion of the cells and necrotic-type cell death
(Miwa et al., 1997; Ridker et al., 1998; Shi and Nuttall,
2007; Sumagin and Sarelius, 2007). More importantly, a
recent study provides evidence that ICAM-1 also plays
an essential role in regulating microvascular permeability,
demonstrating that the overexpression of ICAM-1 signif-
icantly increases the microvascular permeability in wild
type mice, whereas in ICAM-1 deficient animals, the
permeable change is abolished (Sumagin et al., 2008).
This evidence leads us to speculate that the cytotoxic
potential of iNOS and the hemodynamic change by
ICAM-1 and VCAM-1 influence cellular integrity and
energy metabolism in the SV. Moreover, the microvas-
cular hyperpermeability by overproduction of ICAM-1
may contribute to the enlarged intrastrial spaces, where
extensive ramified membranes of marginal cells interdigi-
tate with processes of intermediate cells and capillaries in
order to form the complex networks for ion transporta-
tion and EP production. In accordance with the NF-
jB/Rel family as an essential transcription factor for
innate and adaptive immunity, NF-jB signaling must
have a vital role in cochlear hair cell maintenance and
normal hearing (Nagy et al., 2005; Lang et al., 2006). Its
excessive influence on immune responses, however, fre-
quently leads to self-injurious phenomena such as allergic
diseases (Hart et al., 1998) and secondary inflammatory
injury by ischemia/reperfusion (Cuzzocrea et al., 2001;
Valen et al., 2001; Conti et al., 2007). On the basis of
the evidence, our study suggests that the excess response
of NF-jB signals to acoustic overstimulation causes
marked expression of the inflammatory factors in the
inner ear and the hemodynamics and the cellular integ-
rity in the SV are potentially impacted by the adhesion
molecules (ICAM-1 and VCAM-1) as well as iNOS.
Thus, the regulation of NF-jB signaling might be
meaningful as a future therapeutic target to acoustic
trauma and further studies are needed to elucidate the
control of NF-jB signaling and the regulation of the
specific target gene expressions in the inner ear.
In conclusion, this study provides new information
that the NF-jB/Rel family members NF-jB1, NF-jB2,
RelA, and RelB, as the predominant forms in two sig-
nal-transduction (canonical and noncanonical) pathways,
are induced in the murine inner ear by acoustic oversti-
mulation and the induced inflammatory factors (iNOS,
ICAM-1, and VCAM-1) produced in the CLW are
probably associated with the subsequent histopathological
changes in the SV.
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Tomasello F. 2007. Nitric oxide in the injured spinal cord: synthases
cross-talk, oxidative stress and inflammation. Brain Res Rev 54:205–
218.
Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. 2001. Antioxidant
therapy: a new pharmacological approach in shock, inflammation, and
ischemia/reperfusion injury. Pharmacol Rev 53:135–159.
Denk A, Wirth T, Baumann B. 2000. NF-kappaB transcription factors:
critical regulators of hematopoiesis and neuronal survival. Cytokine
Growth Factor Rev 11:303–320.
Ghosh S, Karin M. 2002. Missing pieces in the NF-kappaB puzzle. Cell
109(Suppl):S81–S96.
Ghosh S, May MJ, Kopp EB. 1998. NF-kappa B and Rel proteins: evo-
lutionarily conserved mediators of immune responses. Annu Rev
Immunol 16:225–260.
Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. 1998. Activa-
tion and localization of transcription factor, nuclear factor-kappaB, in
asthma. Am J Respir Crit Care Med 158:1585–1592.
Sound-induced NF-jB Signaling in the Ear 1839
Journal of Neuroscience Research
Hirose K, Liberman MC. 2003. Lateral wall histopathology and endoco-
chlear potential in the noise-damaged mouse cochlea. J Assoc Res Oto-
laryngol 4:339–352.
Jiang H, Sha SH, Schacht J. 2005. NF-kappaB pathway protects cochlear
hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res
79:644–651
Karin M, Lin A. 2002. NF-kappaB at the crossroads of life and death.
Nat Immunol 3:221–227.
Karin M, Cao Y, Greten FR, Li ZW. 2002. NF-kappaB in cancer: from
innocent bystander to major culprit. Nat Rev Cancer 2:301–310.
Konishi T, Salt AN, Hamrick PE. 1979. Effects of exposure to noise on
ion movement in guinea pig cochlea. Hear Res 1:325–342.
Lang H, Schulte BA, Zhou D, Smythe N, Spicer SS, Schmiedt RA.
2006. Nuclear factor kappaB deficiency is associated with auditory
nerve degeneration and increased noise-induced hearing loss. J Neurosci
26:3541–3550.
Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-Delta Delta C(T))
Method. Methods 25:402–408.
Masuda M, Nagashima R, Kanzaki S, Fujioka M, Ogita K, Ogawa K.
2006. Nuclear factor-kappa B nuclear translocation in the cochlea of
mice following acoustic overstimulation. Brain Res 1068:237–247.
Miwa K, Igawa A, Inoue H. 1997. Soluble E-selectin, ICAM-1 and
VCAM-1 levels in systemic and coronary circulation in patients with
variant angina. Cardiovasc Res 36:37–44.
Moncada S, Palmer RM, Higgs EA. 1991. Nitric oxide: physiology,
pathophysiology, and pharmacology. Pharmacol Rev 43:109–142.
Nagashima R, Sugiyama C, Yoneyama M, Kuramoto N, Kawada K,
Ogita K. 2007. Acoustic overstimulation facilitates the expression of
glutamate–cysteine ligase catalytic subunit probably through enhanced
DNA binding of activator protein-1 and/or NF-kappaB in the murine
cochlea. Neurochem Int 51:209–215.
Nagy I, Monge A, Albinger-Hegyi A, Schmid S, Bodmer D. 2005. NF-
kappaB is required for survival of immature auditory hair cells in vitro.
J Assoc Res Otolaryngol 6:260–268.
Nin F, Hibino H, Doi K, Suzuki T, Hisa Y, Kurachi Y. 2008. The
endocochlear potential depends on two K1 diffusion potentials and an
electrical barrier in the stria vascularis of the inner ear. Proc Natl Acad
Sci U S A 105:1751–1756.
Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J.
1998. Plasma concentration of soluble intercellular adhesion molecule 1
and risks of future myocardial infarction in apparently healthy men.
Lancet 351:88–92.
Rothwarf DM, Karin M. 1999. The NF-kappa B activation pathway: a
paradigm in information transfer from membrane to nucleus. Sci STKE
1999:RE1.
Sen R, Baltimore D. 1986. Inducibility of kappa immunoglobulin
enhancer-binding protein Nf-kappa B by a posttranslational mechanism.
Cell 47:921–928.
Senftleben U, Cao Y, Xiao G, Greten FR, Krähn G, Bonizzi G, Chen
Y, Hu Y, Fong A, Sun SC, Karin M. 2001. Activation by IKKalpha of
a second, evolutionary conserved, NF-kappa B signaling pathway. Sci-
ence 293:1495–1499.
Shi X, Nuttall AL. 2003. Upregulated iNOS and oxidative damage to
the cochlear stria vascularis due to noise stress. Brain Res 967:1–10.
Shi X, Nuttall AL. 2007. Expression of adhesion molecular proteins in
the cochlear lateral wall of normal and PARP-1 mutant mice. Hear
Res 224:1–14.
Siebenlist U, Brown K, Claudio E. 2005. Control of lymphocyte devel-
opment by nuclear factor-kappaB. Nat Rev Immunol 5:435–445.
Sumagin R, Sarelius IH. 2007. A role for ICAM-1 in maintenance of
leukocyte–endothelial cell rolling interactions in inflamed arterioles. Am
J Physiol Heart Circ Physiol 293:H2786–H2798.
Sumagin R, Lomakina E, Sarelius IH. 2008. Leukocyte–endothelial cell
interactions are linked to vascular permeability via ICAM-1 mediated
signaling. Am J Physiol Heart Circ Physiol 295:969–977.
Valen G, Yan ZQ, Hansson GK. 2001. Nuclear factor kappa-B and the
heart. J Am Coll Cardiol 38:307–314.
Wangemann P. 2002. K(1) cycling and its regulation in the cochlea and
the vestibular labyrinth. Audiol Neurootol 7:199–205.
Watanabe K, Inai S, Jinnouchi K, Bada S, Hess A, Michel O, Yagi T.
2002. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide syn-
thase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-
treated mice. Anticancer Res 22:4081–4085.
1840 Yamamoto et al.
Journal of Neuroscience Research
